Botanical species · safety record

Daphne genkwa

The EFSA Compendium of Botanicals holds 16 constituent measurements, 7 adverse-effect records and 1 genotoxicity assay for Daphne genkwa. This page reports what those source records contain and how to reach them. It carries no effect estimate, no dose and no recommendation.

Accepted name in source: Daphne genkwa Siebold & Zucc.

16Constituent measurements
8Safety records
10Cited sources
4Licensed products (Canada)

Also recorded as

Synonyms are carried from the source compendium. A species may be traded and studied under more than one name, which is exactly how a safety record gets lost.

Regulatory presence

Health Canada's Licensed Natural Health Products Database holds 4 licensed products naming Daphne genkwa as a medicinal ingredient, matched on the exact Latin binomial. A licence records that a product met the regulator's requirements for sale in Canada. It is not evidence that the product works.

Extract types on licence

  • Dry

Source material stated

  • Flower buds
  • New material

What the records describe

Constituents measured

  • Daphnane diterpenes3
  • Coumarins2
  • Yuanhuapine2
  • Benzofurans1
  • Elemicin1
  • Furfural1
  • Lignans1
  • Methyleugenol1
  • Yuanhuacine1
  • Yuanhuadine1

Plant parts

  • Bud16
  • Flower4
  • Roots and other underground parts1
  • Stem1
  • stalk1

Preparations

  • Solvent extraction12
  • Essential oil4
  • Powder1

Effect types

  • Systemic4
  • Hepatotoxicity2
  • Reproductive1

Target tissues

  • Liver2
  • Respiratory1
  • Urogenital1

Recorded constituents

What analytical work has found in this species, at which plant part and preparation. A measured constituent is a fact about material, not about effect.

SubstancePlant partPreparationConcentrationAnalytical methodSource
BenzofuransFlowerEssential oil2.7 PercentGC-FIDResolve DOI
Daphnane diterpenesBudSolvent extractionLC-MSResolve DOI
Daphnane diterpenesBudUnspecifiedResolve DOI
Daphnane diterpenesBudSolvent extractionNuclear Magnetic Resonance (NMR)Resolve DOI
ElemicinFlowerEssential oil4.5 PercentGC-FIDResolve DOI
FurfuralFlowerEssential oil2.8 PercentGC-FIDResolve DOI
LignansBudPowderLC-MSResolve DOI
MethyleugenolFlowerEssential oil4.6 PercentGC-FIDResolve DOI
YuanhuacineBudSolvent extraction7.4 Milligram/gramLC-MSResolve DOI
YuanhuadineBudSolvent extraction10.7 Milligram/gramLC-MSResolve DOI
YuanhuafinBudSolvent extraction1.97 Milligram/gramLC-MSResolve DOI
YuanhuapineBudNuclear Magnetic Resonance (NMR)Resolve DOI
YuanhuapineBudSolvent extraction1.31 Milligram/gramLC-MSResolve DOI
YuanhuatineBudSolvent extraction1.04 Milligram/gramLC-MSResolve DOI
CoumarinsStem / stalkSolvent extractionUnspecifiedNo resolvable identifier
CoumarinsRoots and other underground partsUnspecifiedNo resolvable identifier

Recorded adverse effects

Adverse effects reported in the source literature, most often in animal or laboratory models at a stated preparation and dose.

EffectTarget tissuePlant partPreparationTest organismTest typeSource
HepatotoxicityLiverBudSolvent extractionRat (as animal)Acute toxicityResolve DOI
HepatotoxicityLiverBudSolvent extractionRat (as animal)Acute toxicityResolve DOI
ReproductiveUrogenitalBudSolvent extractionIn vitroResolve DOI
SystemicRespiratoryBudSolvent extractionRat (as animal)Acute toxicityResolve DOI
SystemicBudRat (as animal)Acute toxicityResolve DOI
SystemicBudRat (as animal)Acute toxicityResolve DOI
SystemicHouse mouse (as animal)Acute toxicityResolve DOI

Genotoxicity testing

Outcomes of genotoxicity assays as recorded in the source. A negative assay is a result under those test conditions, not a clearance.

OutcomeEndpointTestTested organismMetabolic activationSource
Positivegene mutationbacterial reverse mutation assaySalmonella typhimurium (as organism)Resolve DOI

Cited sources

The literature the compendium cites for this species. Metatron Health has no relationship with these authors or journals and earns nothing from citing them.

  1. Zhang, Yuanyuan., Zhang, Ruowen., Yuan, Yang., Geng, Lulu., Zhao, Xu., Meng, Xia., Zhuang, Hefei., Bi, Kaishun., Chen, Xiaohui. Simultaneous determination of eight active components in chloroform extracts from raw and vinegar-processed Genkwa flos using HPLC-MS and identification of the hepatotoxic ingredients with an HL-7702 cell . Analytical methods, 2014, vol. 6, no. 17, p. 7022-7029. DOI
  2. Yun, Jun-Won., Kim, Seung-Hyun., Kim, Yun-Soon., You, Ji-Ran., Kwon, Euna., Jang, Ja-June., Park, In Ae., Kim, Hee Chan., Kim, Hyeon Hoe., Che, Jeong-Hwan., Kang, Byeong-Cheol. Evaluation of subchronic (13 week) toxicity and genotoxicity potential of vinegar-processed Genkwa Flos . Regulatory toxicology and pharmacology, 2015, vol. 72, no. 2, p. 386-393. DOI
  3. Chen, Yan-Yan., Guo, Jian-Ming., Qian, Ye-Fei., Guo, Sheng., Ma, Chun-Hua., Duan, Jin-Ao. Toxicity of daphnane-type diterpenoids from Genkwa Flos and their pharmacokinetic profile in rat . Phytomedicine, 2013, vol. 21, no. 1, p. 82-89. DOI
  4. Chen, Yanyan., Guo, Jianming., Tang, Yuping., Wu, Liang., Tao, Weiwei., Qian, Yefei., Duan, Jin-ao. Pharmacokinetic profile and metabolite identification of yuanhuapine, a bioactive component in Daphne genkwa by ultra-high performance liquid chromatography coupled with tandem mass spectrometry . Journal of pharmaceutical and biomedical analysis, 2015, vol. 112, p. 60-69. DOI
  5. Ueyama, Y., Hashimoto, S., Nii, H., Furukawa, K. The chemical composition of the essential oil of Daphne genkwa sieb. et zucc.. Journal of essential oil research, 1990, vol. 2, no. 5, p. 247-250. DOI
  6. Li, Lin-Yan., Cao, Fen-Fang., Su, Zhi-Jian., Zhang, Qi-Hao., Dai, Xiao-Yong., Xiao, Xue., Huang, Ya-Dong., Zheng, Qing., Xu, Hua. Assessment of the embryotoxicity of four Chinese herbal extracts using the embryonic stem cell test . Molecular medicine reports, 2015, vol. 12, no. 2, p. 2348-2354. DOI
  7. Kang, Ho-Bum., Lee, Ha-Reum., Jee, Da Jung., Shin, Su-Hyun., Nah, Seong-Su., Yoon, Sun Young., Kim, Jae Wha. PRDM1, a Tumor-Suppressor Gene, is Induced by Genkwadaphnin in Human Colon Cancer SW620 Cells . Journal of cellular biochemistry, 2016, vol. 117, no. 1, p. 172-179. DOI
  8. Zhan, ZJ., Fan, CQ., Ding, J., Yue, HM. Novel diterpenoids with potent inhibitory activity against endothelium cell HMEC and cytotoxic activities from a well-known TCM plant Daphne genkwa . Bioorganic & medicinal chemistry, 2005, vol. 13, no. 3, p. 645-655. DOI
  9. He, Lei., Shi, Qi-rong., Liu, Run-hui., Xu, Xi-ke., Shen, Yun-heng., Li, Hui-liang., Zhang, Wei-dong. Coumarins from the branches of Daphne genkwa. Yaoxue shijian zazhi, 2008, vol. 26, no. 6, p. 441-443.
  10. Shi, Feng., Zheng, Wei-fa. Phenolic constituents from the roots of Daphne genkwa and their immunomodulatory activity. Xuzhou shifan daxue xuebao, ziran kexueban, 2004, vol. 22, no. 4, p. 34-40.

Boundary

A constituent measurement is a fact about material at a stated preparation, not a statement about what that material does in a person. An adverse-effect or genotoxicity record is an observation reported in a source, most often in an animal or laboratory model. Neither is a Metatron Health conclusion about causality, human risk or benefit, and the absence of a record is not proof that a preparation is safe. Nothing here is diagnosis, prescribing or individual medical care.

Continue